The health and safety of our patients is, and always will be, our highest priority. We understand those living with growth hormone deficiency (GHD) and their loved ones may be facing a lot of uncertainty during this pandemic, and we are committed to keeping the communities we serve updated with any information that could help inform health decisions related to our medicines.
During these challenging times, if you are considering stopping or delaying your treatment, please speak with your doctor or healthcare team before doing so, as we recommend that personal treatment decisions should be made between you and your healthcare team. Your doctor will be able to assess the benefits and risks specific to your overall health situation.
If you have experienced a change in insurance or income, or seeking financial assistance or more information on your NUTROPIN treatment, including live virtual no-contact injection training, please call NURSE HOTLINE at 1-866-NUTROPIN (1-866-688-7674) to speak with a nurse or representative.
In addition to local public health guidance, or local guidance specifically issued by medical or patient associations, please find more information on Genentech’s response to the COVID-19 pandemic and other support services on the Genentech website (https://www.gene.com/covid19).
Nutropin AQ® (somatropin) injection for subcutaneous use is a human growth hormone that is available by prescription only.
Doctors prescribe Nutropin therapy for children and teenagers who are short or growing slowly because they:
Doctors prescribe Nutropin therapy for adults who have growth hormone deficiency that began either in:
Your doctor will test to see if growth hormone is right for you.
Please read this Important Safety Information carefully. Then, if you have any questions, talk with your doctor.
What should you tell your doctor before starting Nutropin therapy?
While taking Nutropin, contact your doctor immediately if you experience:
Other important information about Nutropin
What are common possible side effects of Nutropin therapy?
Common side effects reported in adults and children taking Nutropin therapy include injection site reactions. Additional common side effects in adults include swelling, joint pain, and carpal tunnel syndrome.
You may report side effects to FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555.
How should you store Nutropin?
Nutropin must be kept refrigerated (36° to 46°F [2° to 8°C]). Do not freeze. Cartridges and NuSpin pens must be used within 28 days of initial use. Throw away any unused Nutropin after 28 days of initial use. Before giving an injection, check the manufacturer’s expiration date on the cartridge or pen. Do not use if it has expired. Do not inject medication if the solution is cloudy.
Please see accompanying Nutropin full Prescribing Information for additional Important Safety Information.
Sebastian, a Nutropin patient, and his mom, Andrea, walk through the steps associated with using the NuSpin device for Nutropin therapy.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.